Searched for
TYPE 2 DIABETES REVERSAL
More sleep means good health? Answer is... Study says people with diabetes face risk of developing deadly liver disease with rise in nap timeMore sleep means good health? Answer is no. Study says people with diabetes face risk of developing deadly liver disease with rise in nap t...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Two Trades for Today: A city gas distributor for a 9.4% gain, a mid-cap private bank stock for a 5% upmoveOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Indian pharma market's double-digit growth momentum is likely to continue further: EquirusThe Indian Pharmaceutical Market is set for continued double-digit growth. May's performance showed strong demand across all therapies. Chr...
- BigBasket founder's exit; Pocket FM’s reverse flipAmazon veteran Amit Nanda, currently director of selling partner services, now takes over as CEO.
- UAE Lottery Results winner list June 16 updates: Check Pick 3 and Pick 4 winning numbers, prize money, tips before checking results and moreUAE Lottery Results Today (June 16): The UAE Lottery Pick 3 and Pick 4 results for Tuesday, June 16, 2026, have been declared at the offici...
- Air India adds lower-cost ‘Basic’ fare on domestic flights; free meals not includedAir India has launched a new 'Basic' fare for economy class passengers on certain domestic routes. This option offers a lower price for tra...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Cipla appoints health chief Shivam Puri to lead One India businessCipla has appointed Shivam Puri as the new Chief Executive Officer for its One India Business. This significant leadership change will take...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- Anthropic block marks US reversal, warning to Silicon ValleyAmerica has taken a significant step by blocking foreign access to Anthropic's top AI models. This move follows concerns about bypassing se...
- Vedanta demerger & HFCL dip: Anand James reveals how to trade this week's top stock triggersAlso, 23700 is a stiff barrier that had troubled May for several days, and is expected to pose a stiff challenge to further upside. And so ...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Weight-loss drugs trim UK food bills by $1 billionHouseholds with at least one user of GLP-1 weight-loss drugs bought 299 million fewer food items in the year after adoption of the medicati...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
- In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulinIn a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the panc...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to knowFish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diab...
Load More
